A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
Kelsey Bowman extended her medical school program from four years to five years to develop a test to map regions of the brain associated with memory.
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.
A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.
Northwestern Medicine scientists have identified a molecular therapy to prevent the growth of a rare pediatric leukemia.
Second-year medical student Arianna Yanes recently published an editorial in JAMA Internal Medicine about incorporating firearm safety into the medical school curricula.
A recent study explores the use of metabolic markers to target ovarian cancer stem cells and could improve outcomes of existing therapies.
From 3-D printed hyperelastic bones to the nuclear membrane of immature red blood cells, scientific images bring to life the range of research published by Feinberg faculty and students in 2016.
Northwestern Medicine scientists showed how a microRNA family regulates aspects of autophagy and macropinocytosis in the stem cell–enriched limbal epithelium of the eye.